Delivery Order SPE2DR25D2014-SPE2DR26FA1D3
Award Date 12/31/25
Potential Completion Date 1/2/26
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,429.05 delivery order on May 15, 2025, for NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price, non-set-aside award with an ultimate completion date of May 16, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,405.80 for NovoLog 100 Unit/mL FlexPen 3mL insulin pens on September 24, 2025, with completion expected by September 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,919.37 for NovoLog 100 Unit/mL FlexPen 3mL insulin products, with an ultimate completion date of January 2, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters and operations...
- The Defense Logistics Agency awarded a $1,756.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of November 18, 2025. This non-competitive, non-set-aside delivery order represents a routine pharmaceutical procurement to support federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and...
- The Defense Logistics Agency awarded a delivery order valued at $4,711.09 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of November 14, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and identifies Conshohocken, Pennsylvania as the place of performance, which is also the location of AmerisourceBergen's corporate headquarters. The delivery order represents a single transaction...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,670.63 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with completion targeted for December 19, 2025. This competitive, firm fixed-price delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award carries no set-aside designation, indicating it was competed among qualified vendors....
- The Defense Logistics Agency awarded a delivery order valued at $3,941.54 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a completion date of September 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,633.44 for NovoLog 100 Unit/ML FlexPen 3ML insulin pens on November 10, 2025, with an ultimate completion date of November 12, 2025. This non-competitive, firm fixed-price delivery order will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,427.99 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The contract, awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a firm fixed-price delivery under a non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical supply chains, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $33,462.75 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This competitive award, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...